Managlay, Merry-an .
HRN: 07-90-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2025
MUPIROCIN 2%, 15G (TUBE)
09/29/2025
10/06/2025
SKIN
2%
BID
Lesions On Skin
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes